PLASMA CELL MYELOMA RECURRENT

Clinical trials for PLASMA CELL MYELOMA RECURRENT explained in plain language.

Never miss a new study

Get alerted when new PLASMA CELL MYELOMA RECURRENT trials appear

Sign up with your email to follow new studies for PLASMA CELL MYELOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Cancer trial tests quick shot vs lengthy IV for myeloma

Disease control Ongoing

This study is testing if a cancer drug called isatuximab works just as well when given as a shot under the skin (subcutaneous) compared to the standard method of an IV drip. It involves 531 adults with multiple myeloma that has returned or stopped responding to prior treatments. …

Matched conditions: PLASMA CELL MYELOMA RECURRENT

Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control

Last updated Apr 04, 2026 03:35 UTC

PLASMA CELL MYELOMA RECURRENT

Get alerted when new PLASMA CELL MYELOMA RECURRENT trials appear

Cancer trial tests quick shot vs lengthy IV for myeloma